F. Sitas et al., ASSOCIATION BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ANDCANCER IN THE BLACK-POPULATION OF JOHANNESBURG AND SOWETO, SOUTH-AFRICA, British Journal of Cancer, 75(11), 1997, pp. 1704-1707
A case-control study of 913 black cancer patients (aged 15-50 years) w
as undertaken to measure the association between human immunodeficienc
y (HIV) infection and cancers believed to have an infective aetiology.
Controls were patients with cancers believed not to be infective in o
rigin. The prevalence of HIV in the controls of 7.3% (24 of 325) was s
imilar to the background HIV seropositivity in this population. Odds r
atios (ORs) and 95% confidence intervals (CI) adjusted for age, year o
f diagnosis, marital status and sex were calculated. There was a stron
g association between HIV infection and Kaposi's sarcoma (KS), with 27
of 33 cases being HIV seropositive, OR = 61.8 (95% CI 19.7-194.2) and
an elevated association with non-Hodgkin's lymphoma (NHL), with 27 of
40 cases being HIV seropositive [OR = 4.8 (95% CI 1.5-14.8)]. The ele
vated odds ratio for KS associated with HIV infection accords with the
observed increases in the incidence of KS in several sub-Saharan Afri
can countries where the prevalence of HIV is high. The odds ratio for
NHL associated with HIV infection was lower than that reported in deve
loped countries, and the reason for this is not clear. No other cancer
s, including cervical and liver cancers, showed significantly elevated
odds ratios associated with HIV infection.